Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone for Military-Related Chronic PTSD
NCT00099983Phase 2Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Oct 2006
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of risperidone in post-traumatic stress disorder (PTSD), sponsored by United States Department of Veterans Affairs. Started Oct 2006; status: completed.
02
Drugs
risperidone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00099983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00099983.